Articles/ Healthcare/ UK & Europe/ Views and analysis Will UK patients get access to novel drugs? Andrew McConaghie NHS England, NICE, Quintiles IMS Market Access Summit, quintilesIMS, UK market access 0 Comment Access to new medicines is not high up the list of priorities for NHS England, but pharma must seize opportunities to promote innovation uptake. Share X Will UK patients get access to novel drugs? https://pharmaphorum.com/views-and-analysis/will-uk-patients-get-access-to-novel-drugs/